Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Mitochondrial Permeability Transition Pore Assay Kit: Applie
2026-06-17
Unlock robust, quantitative insights into mitochondrial membrane dynamics using the Mitochondrial Permeability Transition Pore Assay Kit. This guide translates advanced research into optimized experimental workflows, actionable troubleshooting, and next-generation applications in cell death mechanism studies.
-
Nebulized Risedronate Sodium Microspheres Target Emphysema v
2026-06-17
This study pioneers the use of nebulized Risedronate Sodium-chitosan microspheres to attenuate pulmonary emphysema by inducing alveolar macrophage apoptosis, offering a targeted and effective inhalation therapy. The approach achieves deep lung deposition and minimizes cytotoxicity, marking a significant advance in both drug repurposing and respiratory drug delivery strategies.
-
V5 Epitope Tag Peptide: Precision Tagging for Protein Detect
2026-06-16
The V5 Epitope Tag Peptide is a 14-amino-acid synthetic tag enabling high-specificity protein tagging in Western blotting and immunoprecipitation. Its sequence, GKPIPNPLLGLDST, supports robust antibody detection, reproducibility, and solubility across workflows. Peer-reviewed benchmarks confirm its role as a gold-standard recombinant protein expression tag.
-
Clodronate Liposomes: Precision In Vivo Macrophage Depletion
2026-06-16
Clodronate Liposomes empower researchers to selectively deplete macrophages in vivo, unlocking new insights into immune cell modulation and therapy resistance. This guide details optimized workflows, troubleshooting, and advanced applications, bridging protocol design with the latest tumor immunology breakthroughs.
-
TBXA2R-ERM Signaling Drives Metastasis in TNBC Cells
2026-06-15
This study reveals that the thromboxane A2 receptor (TBXA2R), a GPCR, activates the ERM protein family to promote motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC) cells. The work uncovers a previously uncharacterized signaling axis, offering new insights for the development of targeted anti-metastatic strategies and highlighting the role of GPCR signaling in tumor progression.
-
Surfactant-Derived LNPs Advance mRNA Delivery to Macrophages
2026-06-15
This study presents a dual-component lipid nanoparticle (LNP) platform, using surfactant-derived ionizable lipids, for efficient mRNA delivery to macrophages. The work addresses the challenge of non-viral mRNA transfection in hard-to-engineer immune cells, offering new routes for gene regulation and immunomodulation studies.
-
MLN2238: Precision Proteasome β5 Subunit Inhibitor Workflows
2026-06-14
MLN2238 is reshaping proteasome β5 subunit inhibitor applications in oncology and proteostasis research, including studies on bortezomib-resistant cancers. This guide translates the latest mechanistic and workflow advances into actionable protocols, bridging high-impact discoveries with troubleshooting strategies for reproducible results.
-
Metformin Hydrochloride: Protocols and Innovations in Fibros
2026-06-13
Metformin Hydrochloride (Metformin HCl) is redefining research on fibrosis and metabolic regulation by precisely targeting AMPK signaling. This article details actionable protocols, troubleshooting strategies, and advanced applications—bridging metabolic and tissue remodeling models with confidence.
-
SB 431542: Precision ALK5 Inhibitor for TGF-β Pathway Studie
2026-06-12
SB 431542 delivers unmatched selectivity as an ALK5 inhibitor, empowering researchers to dissect TGF-β signaling in stem cell, cancer, and immunology models. This guide translates the latest research and peer-validated protocols into actionable steps, with troubleshooting and optimization strategies for robust, reproducible results.
-
BIRB 796 (Doramapimod): Precision p38α MAPK Inhibition in Re
2026-06-12
BIRB 796 (Doramapimod) empowers researchers with unparalleled selectivity and dual-action inhibition of p38α MAPK, enabling robust inflammation and apoptosis assays. Recent mechanistic advances reveal unique conformational effects, guiding protocol refinement and troubleshooting for high-impact discoveries.
-
SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Resear
2026-06-11
SB 431542, an ALK5 inhibitor, empowers researchers to dissect TGF-β signaling in models of fibrosis, cancer, and immunology. This article details advanced workflows, troubleshooting, and key innovations for maximizing SB 431542's impact in cell-based and in vivo experiments.
-
Etomoxir in Fatty Acid Oxidation Pathway Research: Protocols
2026-06-11
Etomoxir, a potent CPT-1 inhibitor from APExBIO, empowers researchers to dissect fatty acid oxidation in immune and metabolic studies. This article translates standardized immunometabolism workflows and troubleshooting strategies for reproducible, data-rich experiments.
-
SIS3 (Smad3 Inhibitor): Precision Modulation in Fibrosis Res
2026-06-10
Discover how SIS3, a selective Smad3 inhibitor, enables targeted modulation of the TGF-β signaling pathway for advanced fibrosis and osteoarthritis research. This article offers a deeper exploration of assay design and molecular insights, setting a new benchmark for translational studies.
-
LY364947: Precision TGF-β Type I Receptor Kinase Inhibitor i
2026-06-10
LY364947 enables robust, selective inhibition of TGF-β signaling for translational research across EMT, fibrosis, and retinal degeneration models. Discover workflow-optimized protocols, troubleshooting insights, and cross-study innovations that set APExBIO’s LY364947 apart in both in vitro and in vivo applications.
-
Atomic Mechanisms of DED Assembly in Apoptosis Regulation
2026-06-09
This study elucidates the previously unresolved atomic structure of the human FADD-procaspase-8-cFLIP complex, a pivotal regulator in death receptor-mediated apoptosis and necroptosis. By integrating X-ray crystallography and cryo-EM, the research offers new mechanistic insights that refine our understanding of apoptosis signaling and its potential manipulation in disease contexts.